Pharmaceutical and life sciences companies are in the cross-hairs when it comes to third-party and supply chain risk management. With a huge reliance on third parties across almost every phase of their businesses, a range of general and specific laws and regulations to adhere to, and a surge in cyber-attackson their data assets by malicious players, it’s no wonder that companies struggle to keep up.
COVID-19 has only exacerbated challenges to the industry with business disruption, economic uncert
